| Seldin, David C; Lou, David Y; Toselli, Paul et al. (2008) Gene targeting of CK2 catalytic subunits. Mol Cell Biochem 316:141-7 |
| Lou, David Y; Dominguez, Isabel; Toselli, Paul et al. (2008) The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development. Mol Cell Biol 28:131-9 |
| Mork, C N; Faller, D V; Spanjaard, R A (2005) A mechanistic approach to anticancer therapy: targeting the cell cycle with histone deacetylase inhibitors. Curr Pharm Des 11:1091-104 |
| Seldin, David C; Landesman-Bollag, Esther; Farago, Marganit et al. (2005) CK2 as a positive regulator of Wnt signalling and tumourigenesis. Mol Cell Biochem 274:63-7 |
| Marecki, Sylvia; McCarthy, Kevin M; Nikolajczyk, Barbara S (2004) PU.1 as a chromatin accessibility factor for immunoglobulin genes. Mol Immunol 40:723-31 |
| Heldwein, Kurt A; Liang, Michael D; Andresen, Tonje K et al. (2003) TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J Leukoc Biol 74:277-86 |
| McCarthy, Kevin M; McDevit, Daniel; Andreucci, Amy et al. (2003) HMGA1 co-activates transcription in B cells through indirect association with DNA. J Biol Chem 278:42106-14 |
| Andreucci, Amy; Reeves, Raymond; McCarthy, Kevin M et al. (2002) Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism. Biochem Biophys Res Commun 292:427-33 |
| Gregory, Meredith S; Repp, Amanda C; Holhbaum, Andreas M et al. (2002) Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J Immunol 169:2727-35 |
| Lynch, E M; Moreland, R B; Ginis, I et al. (2001) Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. Am J Physiol Cell Physiol 280:C897-911 |
Showing the most recent 10 out of 21 publications
